An open study of Auranofin in the treatment of steroid-dependent asthma
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 81 (1) , 6-16
- https://doi.org/10.1016/0091-6749(88)90213-8
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Auranofin modulates mast cell histamine and polymorphonuclear leukocyte collagenase releaseInflammation Research, 1986
- Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofinInflammation Research, 1986
- Inhibition by auranofin of pharmacologic and antigen-induced contractions of the isolated guinea pig tracheaJournal of Allergy and Clinical Immunology, 1986
- Auranofin, an oral chrysotherapeutic agent, inhibits histamine release from human basophilsJournal of Allergy and Clinical Immunology, 1984
- Biologic actions and pharmacokinetic studies of auranofinThe American Journal of Medicine, 1983
- Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritisArthritis & Rheumatism, 1983
- Bronchial responsiveness to acethylcholine in patients with bronchial asthma after long-term treatment with gold saltJournal of Allergy and Clinical Immunology, 1981
- Standardization of bronchial inhalation challenge proceduresJournal of Allergy and Clinical Immunology, 1975
- Leukocyte Migration Inhibition in Nickel DermatitisInternational Archives of Allergy and Immunology, 1975
- STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENAThe Journal of Experimental Medicine, 1964